Company Filing History:
2 out of 6 
1 out of 1 
1 out of 1 Years Active: 2012-2015
Title: Santo Landolfo: Innovator in Therapeutic Agents
Introduction
Santo Landolfo is a notable inventor based in Turin, Italy, recognized for his contributions to the field of biotechnology. With a total of five patents to his name, he has made significant strides in developing therapeutic agents aimed at treating various diseases.
Latest Patents
One of his latest patents is titled "Extracellular IFI16 as therapeutic agents." This invention focuses on inhibiting the circulating extracellular form of the interferon-inducible protein 16 (extracellular IFI16) for the treatment of autoimmune, inflammatory, and infectious disorders. Another significant patent is "Antipathogenic peptides," which relates to monomeric and multimeric peptidic compounds exhibiting antipathogenic activity, particularly against a broad spectrum of viruses and bacteria. These peptide compounds are designed for medical use, specifically for the treatment or prevention of viral and bacterial infections.
Career Highlights
Throughout his career, Santo Landolfo has worked with various companies, including Ribovax Biotechnologies S.a. and Spiderbiotech S.r.l. His work in these organizations has contributed to advancements in therapeutic solutions and innovative biotechnological applications.
Collaborations
Santo has collaborated with notable individuals in his field, including Giorgio Gribaudo and David Lembo. These partnerships have fostered a collaborative environment that enhances research and development in biotechnology.
Conclusion
Santo Landolfo's innovative work in therapeutic agents and his collaborations with esteemed colleagues highlight his significant impact on the biotechnology industry. His patents reflect a commitment to addressing critical health challenges through scientific innovation.